Jamp Digoxin tablet recall in Canada: Product quality issue
In plain language
This recall involves Jamp Digoxin 0.0625 mg tablets sold in Canada. They are being recalled because some tablets may be oversized. Stop using oversized tablets and follow the return steps in the official notice.
What to do
- Stop using any Jamp Digoxin tablets that appear oversized.
- Return your Jamp Digoxin 0.0625 mg tablets to your pharmacy for replacement.
- Contact a healthcare professional if you experience serious side effects.
- Contact JAMP Pharma Corporation with questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Jamp Digoxin tablet
Lot: EG23DGX001
Why this matters
Overdose risk from oversized tablets
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: EG23DGX001
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Overdose risk from oversized tablets
What should consumers do?
Stop using any Jamp Digoxin tablets that appear oversized. Return your Jamp Digoxin 0.0625 mg tablets to your pharmacy for replacement. Contact a healthcare professional if you experience serious side effects. Contact JAMP Pharma Corporation with questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Overdose risk from oversized tablets
When was this product recalled?
This product was recalled on June 3, 2024.
Is the JAMP brand affected by this recall?
Yes, JAMP products are affected by this recall. This recall involves Jamp Digoxin 0.0625 mg tablets sold in Canada. They are being recalled because some tablets may be oversized. Stop using oversized tablets and follow the return steps in the official notice.